What is the generic name?

VORINOSTAT

What is the Trade Name for VORINOSTAT?

ZOLINZA

What are the Indications for VORINOSTAT?

• 1 INDICATIONS AND USAGE ZOLINZA ¬Æ is indicated for the treatment of cutaneous manifestations in patients with cutaneous T-cell lymphoma who have progressive, persistent or recurrent disease on or following two systemic therapies. ZOLINZA is a histone deacetylase (HDAC) inhibitor indicated for the treatment of cutaneous manifestations in patients with cutaneous T-cell lymphoma (CTCL) who have progressive, persistent or recurrent disease on or following two systemic therapies. ( 1 )

References: https://open.fda.gov/